Molecular hydrogen therapy has been the subject of various clinical studies exploring its potential health benefits and applications. The most noteworthy areas of research and findings from clinical studies regarding molecular hydrogen booster therapy is its proven antioxidant capacity. It is proven that it reduces inflammation markers and enhances the cellular function in the body.
The trials have demonstrated the following therapeutic effects in these major disease areas:
Cardiovascular Diseases: Improved outcomes in conditions like myocardial infarction and post-cardiac arrest syndrome with H₂ inhalation or water consumption. Benefits include reduced oxidative stress and inflammation.
Cancer: H₂ therapy reduces tumor progression and alleviates side effects of standard cancer treatments (e.g., chemotherapy, radiotherapy). It shows promise in modulating immune responses, such as reducing PD-1 expression in T-cells.
Respiratory Diseases: Positive effects in chronic obstructive pulmonary disease (COPD), asthma, and COVID-19 patients. Notably, H₂ inhalation is included in China’s national COVID-19 treatment guidelines.
Central Nervous System Disorders: H₂ therapy shows benefits for brain ischemia, Alzheimer’s disease, and Parkinson’s disease in small-scale trials, though large-scale trials yield mixed results.
Infections: Promising results in reducing inflammation and improving respiratory function in COVID-19 patients.
Lifestyle-Related Diseases: Positive outcomes in type 2 diabetes, obesity, and metabolic syndrome, including improvements in blood sugar control, lipid profiles, and weight reduction.
Other Conditions: Rheumatoid arthritis, non-alcoholic fatty liver disease (NAFLD), and hemodialysis-related inflammation showed significant improvements.